These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 442591

  • 1. [Disorders of oxidative deamination of biogenic amines in the myocardium in experimental atherosclerosis].
    Brusova EG, Krivchenkova RS.
    Vopr Med Khim; 1979; 25(2):198-204. PubMed ID: 442591
    [Abstract] [Full Text] [Related]

  • 2. [Properties of monoamine oxidases from myocardial mitochondria].
    Krivchenkova RS, Brusova EG.
    Vopr Med Khim; 1977; (6):834-40. PubMed ID: 595488
    [Abstract] [Full Text] [Related]

  • 3. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS, Klimova GI, Nersisian AA.
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [Abstract] [Full Text] [Related]

  • 4. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP, Mostiaeva LV.
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [Abstract] [Full Text] [Related]

  • 5. Evidence for a clorgyline-resistant monoamine metabolizing activity in the rat heart.
    Lyles GA, Callingham BA.
    J Pharm Pharmacol; 1975 Sep; 27(9):628-91. PubMed ID: 241805
    [Abstract] [Full Text] [Related]

  • 6. [Features of the biochemical action of paraquat on oxidative deamination of biogenic amines and other nitrogen compounds].
    Amanov K, Mamadiev M, Khuzhamberdiev MA, Gorkin VZ.
    Vopr Med Khim; 1994 Sep; 40(4):22-8. PubMed ID: 7975374
    [Abstract] [Full Text] [Related]

  • 7. [Mechanism of disturbances in the deamination of nitrogenous compounds in experimental hypercholesterolemia and atherosclerosis].
    Khuzhamberdiev M, Mamadiev M, Gorkin VZ.
    Vopr Med Khim; 1981 Sep; 27(6):829-35. PubMed ID: 7336659
    [Abstract] [Full Text] [Related]

  • 8. Monoamine and diamine oxidative deamination in the longitudinal smooth muscle of guinea pig ileum.
    Banchelli G, Raimondi L, Ignesti G, Pirisino R, Buffoni F.
    Med Biol; 1985 Sep; 63(1):34-9. PubMed ID: 3999819
    [Abstract] [Full Text] [Related]

  • 9. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS.
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [Abstract] [Full Text] [Related]

  • 10. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS.
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [Abstract] [Full Text] [Related]

  • 11. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY, Neff NH.
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract] [Full Text] [Related]

  • 12. [Biogenic amine deamination in experimental tuberculosis].
    Gorkin VZ, Elistratova NA.
    Vopr Med Khim; 1979 Jun; 25(6):743-8. PubMed ID: 516536
    [Abstract] [Full Text] [Related]

  • 13. Lipid peroxidation in mitochondrial membranes induced by enzymatic deamination of biogenic amines.
    Kagan VE, Smirnov AV, Savov VM, Prilipko LL, Gorkin VZ.
    Acta Physiol Pharmacol Bulg; 1983 Jun; 9(4):3-13. PubMed ID: 6677061
    [Abstract] [Full Text] [Related]

  • 14. [Peroxidation of lipids in mitochondrial membranes, induced by enzymatic deamination of biogenic amines].
    Kagan VE, Smirnov AV, Savov VM, Gorkin VZ.
    Vopr Med Khim; 1984 Jun; 30(1):112-8. PubMed ID: 6710929
    [Abstract] [Full Text] [Related]

  • 15. [Changes in kinetics of deaminated biogenic amines in spontaneous hypertension].
    Ioffina DI, Smirnov IE, Gorkin VZ.
    Vopr Med Khim; 1991 Jun; 37(1):59-63. PubMed ID: 1858344
    [Abstract] [Full Text] [Related]

  • 16. Some factors influencing the metabolism of benzylamine by type A and B monoamine oxidase in rat heart and liver.
    Parkinson D, Lyles GA, Browne BJ, Callingham BA.
    J Pharm Pharmacol; 1980 Dec; 32(12):844-50. PubMed ID: 6110749
    [Abstract] [Full Text] [Related]

  • 17. Deamination of biogenic amines and other nitrogenous compounds in granulation tissue from experimental wounds.
    Romanova LA, Stalnaya ID, Gorkin VZ.
    Med Biol; 1975 Aug; 53(4):205-9. PubMed ID: 1186318
    [Abstract] [Full Text] [Related]

  • 18. [Inhibition of gamma-amylase of the rabbit liver by biogenic amines and products of their oxidative deamination].
    Popova IA, Verevkina IV.
    Vopr Med Khim; 1983 Aug; 29(6):120-3. PubMed ID: 6422628
    [Abstract] [Full Text] [Related]

  • 19. [Brain monoamine oxidase in craniocerebral trauma].
    Akopian AS, Promyslov MSh.
    Vopr Med Khim; 1984 Aug; 30(1):75-7. PubMed ID: 6710942
    [Abstract] [Full Text] [Related]

  • 20. Effect of MAO inhibitors on the high-affinity reuptake of biogenic amines in rat subcortical regions.
    Tekes K, Magyar K.
    Neurobiology (Bp); 2000 Aug; 8(3-4):257-64. PubMed ID: 11225517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.